Natixis »

Inhibrx Biosciences shares owned by Natixis

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Natixis

Quarter filed Position value Share count Share price at filing
2024-09-30 $31k 2.0k 15.66
2024-06-30 $28k 2.0k 14.17

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr Indl (XLI)
Meta Platforms Cl A (META)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Energy Transfer Com Ut Ltd Ptn (ET)
Tesla Motors (TSLA)
salesforce (CRM)
Micron Technology (MU)

View all positions for Natixis

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Geode Capital Management
Morgan Stanley
Caption Management
Kennedy Capital Management
Arrowpoint Asset Management
Susquehanna International
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences